Endogena Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Endogena Therapeutics's estimated annual revenue is currently $1.6M per year.
- Endogena Therapeutics's estimated revenue per employee is $77,500
- Endogena Therapeutics's total funding is $29M.
Employee Data
- Endogena Therapeutics has 21 Employees.
- Endogena Therapeutics grew their employee count by -5% last year.
Endogena Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO and Co-Founder | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Development Officer | Reveal Email/Phone |
5 | Head in vivo pharmacology | Reveal Email/Phone |
6 | Head Development | Reveal Email/Phone |
7 | Head Toxicology | Reveal Email/Phone |
8 | Head Finance | Reveal Email/Phone |
9 | Scientist & Investor Relations | Reveal Email/Phone |
10 | Senior Scientist | Reveal Email/Phone |
Endogena Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Endogena Therapeutics?
endogena’s mission is to discover and develop first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs. our approach has the potential for a medical treatment paradigm change to effectively address unmet medical needs associated with ageing and genetic diseases. endogena therapeutics is implementing state-of-the art innovation in the field of regenerative medicine. our science combines the latest developments in stem cell biology, artificial intelligence and our expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases. recent breakthroughs in stem cell biology together with technological advances for phenotypic, functional screening have unlocked our ability to harness the potential of adult stem- and precursor cells. our novel drug discovery approach is based on the concept of selective activation of endogenous progenitor cells for controlled tissue repair and regeneration by small molecules.
keywords:N/A
$29M
Total Funding
21
Number of Employees
$1.6M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Endogena Therapeutics News
Its current pipeline includes: Endogena Therapeutics (Switzerland/Canada, also founded by Matthias Steger), Rejuveron Senescence...
Other Companies in Zürich
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 21 | 0% | N/A |
#2 | $3.7M | 21 | -32% | N/A |
#3 | $2.1M | 21 | 17% | N/A |
#4 | $2.1M | 21 | -22% | N/A |
#5 | $3.2M | 21 | -19% | N/A |